Vaccination in high-risk groups of people may begin within the next few days, he writes BBC. The United Kingdom has ordered 40 million doses, which should be enough to vaccinate 20 million people. To properly protect a person, the vaccine must be given in two doses three weeks apart by doctors.
–
According to the BBC, approximately 10 million doses should be available soon, the first 800,000 doses according to the web The Times will arrive in the UK in the coming days. According to the British government, health workers and residents of nursing homes are the first in line, and the vaccine should generally be given to the elderly, writes AP.
–
The vaccine was approved for emergency use by the Medicines Regulatory Agency (MHRA) before the rest of Europe and the United States decided. Following Brexit, the MHRA will be fully responsible for the marketing authorization of medicines in the United Kingdom.
–
Help is on its way.
The MHRA has formally authorised the Pfizer/BioNTech vaccine for Covid-19.
The NHS stands ready to start vaccinating early next week.
The UK is the first country in the world to have a clinically approved vaccine for supply.
— Matt Hancock (@MattHancock) December 2, 2020
–
“Help is on the way. The MHRA approved the covid-19 vaccine from Pfizer and BioNTech for use. The State Health System (NHS) is ready to begin vaccination early next week. Britain is the first country in the world to be ready to distribute a clinically approved vaccine, “Health Minister Matt Hancock wrote on Twitter.
–
Hancock according to the web The Guardian He added that distributing the vaccine throughout the UK would be “difficult” because the vaccine had to be kept at -70 degrees Celsius. But Pfizer says the vaccine says the vaccine will last up to five days in a regular refrigerator, which could give the NHS more flexibility in working with the vaccine.
–
Hancock also stated that the country could return to some normalcy around Easter, and suggested that no restrictions might be needed from the summer of 2021. According to him, at least 50 hospitals are currently ready for vaccination, and special vaccination centers are also being set up.
–
“Today’s emergency use of the vaccine in the UK marks a historic moment in the fight against covid-19. We have been working on this goal since we first declared science to win. The NHS has decades of experience implementing large-scale vaccination programs. He will now begin extensive preparations to provide care and support to all those entitled to vaccinations, ”said Pfizer CEO Albert Bourla.
–
“But it is crucial for the success of the vaccination program that everyone continues to play their part and comply with the necessary restrictions so that we can continue to suppress the virus and allow the NHS to do its job without being overwhelmed,” Bourla said.
–
“It’s fantastic that the MHRA has formally approved the covid-19 vaccine. The vaccine will be available in the UK from next week. It is precisely the protection afforded by vaccines that will bring our lives back and stir up the economy, “wrote British Prime Minister Boris Johnson on Twitter.
–
It’s the protection of vaccines that will ultimately allow us to reclaim our lives and get the economy moving again. (2/2)
— Boris Johnson (@BorisJohnson) December 2, 2020
–
In November, the company informed the public about the successful last phase of clinical trials. The covid-19 vaccine developed by Pfizer and BioNTech is 95 percent effective according to the first set of final results from the last phase of the tests and has no serious side effects. According to the statement at the time, the vaccine also works well in the elderly and in preventing the serious course of the infection.
–
The DPA previously reported that Pfizer and BioNTech had applied for vaccine registration in Britain, Australia, Canada and Japan. The Pfizer and BioNTech vaccine may soon be distributed in the United States, according to CNN the first Americans could be vaccinated around December 15. Pfizer applied to the US Food and Drug Administration (FDA) ten days ago. Independent advisors are due to give their FDA advice on the Pfizer vaccine on December 10.
–
The purchase of up to 300 million doses of this vaccine was approved by the European Commission in November, and companies also applied for approval for extraordinary use of the substance in the United States in November. Dozens of companies around the world are also working on the development of other vaccines. The British authorities are also considering another substance from the pharmaceutical company AstraZeneca, whose vaccines Britain has ordered 100 million doses.
—
